Iman Salahshourifar1, Vui King Vincent-Chong1, Hong-Yun Chang1, Hooi Leng Ser1, Anand Ramanathan1,2, Thomas George Kallarakkal1,2, Zainal Ariff Abdul Rahman1,2, Siti Mazlipah Ismail1,2, Narayanan Prepageran1,3, Wan Mahadzir Wan Mustafa4, Mannil Thomas Abraham5, Keng Kiong Tay6, Rosnah Binti Zain7,8. 1. Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia. 2. Department of Oro-Maxillofacial Surgical and Medical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia. 3. Department of Otorhinolaringology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 4. Department of Oral and Maxillofacial Surgery, Hospital Kuala Lumpur, Ministry of Health Malaysia, Kuala Lumpur, Malaysia. 5. Department of Oral and Maxillofacial Surgery, Hospital Tengku Ampuan Rahimah, Ministry of Health Malaysia, Klang, Malaysia. 6. Department of Oral Surgery, Hospital Umum Sarawak, Ministry of Health Malaysia, Kuching, Sarawak, Malaysia. 7. Oral Cancer Research and Coordinating Centre, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia. rosnahbz12@yahoo.com. 8. Department of Oro-Maxillofacial Surgical and Medical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia. rosnahbz12@yahoo.com.
Abstract
OBJECTIVES: This study includes the direct sequencing of cornulin (CRNN) gene to elucidate the possible mechanism of CRNN downregulation and explore the genetic imbalances at 1q21.3 across oral squamous cell carcinoma (OSCC) samples. MATERIALS AND METHODS: In mutation screening of CRNN gene, gDNA from OSCC tissues were extracted, amplified, and followed by direct sequencing. OSCC samples were also subjected to fragment analysis on CRNN gene to investigate its microsatellite instability (MSI) and loss of heterozygosity (LOH). Immunohistochemistry was performed to validate CRNN downregulation in OSCC samples. RESULTS: No pathogenic mutation was found in CRNN gene, while high frequency of allelic imbalances was found at 1q21.3 region. MSI was found more frequent (25.3 %) than LOH (9.3 %). Approximately 22.6 % of cases had high MSI which reflects higher probability of inactivation of DNA mismatch repair genes. MSI showed significant association with no betel quid chewing (p = 0.003) and tongue subsite (p = 0.026). LOH was associated with ethnicity (p = 0.008) and advanced staging (p = 0.039). The LOH at 1q21.3 was identified to be as an independent prognostic marker in OSCC (HRR = 7.15 (95 % CI, 1.41-36.25), p = 0.018). Downregulation of CRNN was found among MSI-positive OSCCs and was associated with poor prognosis (p = 0.044). CONCLUSION: This study showed a significant correlation between LOH/MSI at 1q21.3 with clinical outcomes and that downregulation of CRNN gene could be considered as a prognostic marker of OSCC. CLINICAL RELEVANCE: Insights of the downregulation mode of CRNN gene lays the basis of drug development on this gene as well as revealing its prognostic value.
OBJECTIVES: This study includes the direct sequencing of cornulin (CRNN) gene to elucidate the possible mechanism of CRNN downregulation and explore the genetic imbalances at 1q21.3 across oral squamous cell carcinoma (OSCC) samples. MATERIALS AND METHODS: In mutation screening of CRNN gene, gDNA from OSCC tissues were extracted, amplified, and followed by direct sequencing. OSCC samples were also subjected to fragment analysis on CRNN gene to investigate its microsatellite instability (MSI) and loss of heterozygosity (LOH). Immunohistochemistry was performed to validate CRNN downregulation in OSCC samples. RESULTS: No pathogenic mutation was found in CRNN gene, while high frequency of allelic imbalances was found at 1q21.3 region. MSI was found more frequent (25.3 %) than LOH (9.3 %). Approximately 22.6 % of cases had high MSI which reflects higher probability of inactivation of DNA mismatch repair genes. MSI showed significant association with no betel quid chewing (p = 0.003) and tongue subsite (p = 0.026). LOH was associated with ethnicity (p = 0.008) and advanced staging (p = 0.039). The LOH at 1q21.3 was identified to be as an independent prognostic marker in OSCC (HRR = 7.15 (95 % CI, 1.41-36.25), p = 0.018). Downregulation of CRNN was found among MSI-positive OSCCs and was associated with poor prognosis (p = 0.044). CONCLUSION: This study showed a significant correlation between LOH/MSI at 1q21.3 with clinical outcomes and that downregulation of CRNN gene could be considered as a prognostic marker of OSCC. CLINICAL RELEVANCE: Insights of the downregulation mode of CRNN gene lays the basis of drug development on this gene as well as revealing its prognostic value.
Authors: Rosnah Binti Zain; Vimmitra Athirajan; Wan Maria Nabillah Ghani; Ishak Abdul Razak; Raja Jalaludin Raja Latifah; Siti Mazlipah Ismail; Atiya Abdul Sallam; Anita Zarina Bustam; Zainal Ariff Abdul Rahman; Adam Hussien; Norain Talib; Sok Ching Cheong; Amin Jallaludin Journal: Cell Tissue Bank Date: 2012-02-29 Impact factor: 1.522
Authors: C S Ishwad; R E Ferrell; K M Rossie; B N Appel; J T Johnson; E N Myers; J C Law; S Srivastava; S M Gollin Journal: Int J Cancer Date: 1995-10-20 Impact factor: 7.396
Authors: A Liedén; E Ekelund; I-C Kuo; I Kockum; C-H Huang; L Mallbris; S P Lee; L K Seng; G Y Chin; C-F Wahlgren; C N A Palmer; B Björkstén; M Ståhle; M Nordenskjöld; M Nordensköld; M Bradley; K Y Chua; M D'Amato Journal: Allergy Date: 2008-12-24 Impact factor: 13.146
Authors: Laura Romas; Kenzie Birse; Kenneth H Mayer; Max Abou; Garrett Westmacott; Rebecca Giguere; Irma Febo; Ross D Cranston; Alex Carballo-Diéguez; Ian McGowan; Adam Burgener Journal: AIDS Res Hum Retroviruses Date: 2016-08-02 Impact factor: 2.205
Authors: Joe Abdo; Christopher S Wichman; Nicholas E Dietz; Pawel Ciborowski; John Fleegel; Sumeet K Mittal; Devendra K Agrawal Journal: Front Oncol Date: 2018-05-09 Impact factor: 6.244
Authors: Padmanabha Kumar Govindaraj; Thomas George Kallarakkal; Rosnah Mohd Zain; Wanninayake Mudiyanselage Tilakaratne; Huai Lin Lew Journal: PLoS One Date: 2021-12-23 Impact factor: 3.240